-
1
-
-
0037116565
-
High coronary artery calcium scores pose an extremely elevated risk for hard events
-
R. Wayhs, A. Zelinger, and P. Raggi High coronary artery calcium scores pose an extremely elevated risk for hard events J Am Coll Cardiol 39 2002 225 330
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 225-330
-
-
Wayhs, R.1
Zelinger, A.2
Raggi, P.3
-
2
-
-
0042885985
-
Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality
-
G.M. London, A.P. Guerin, S.J. Marchais, F. Metivier, B. Pannier, and H. Adda Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality Nephrol Dial Transplant 18 2003 1731 1740
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 1731-1740
-
-
London, G.M.1
Guerin, A.P.2
Marchais, S.J.3
Metivier, F.4
Pannier, B.5
Adda, H.6
-
3
-
-
1542347890
-
Vascular calcification in chronic kidney disease
-
W.G. Goodman, G. London, K. Amann, G.A. Block, C. Giachelli, and K.A. Hruska Vascular calcification in chronic kidney disease Am J Kidney Dis 43 2004 572 579
-
(2004)
Am J Kidney Dis
, vol.43
, pp. 572-579
-
-
Goodman, W.G.1
London, G.2
Amann, K.3
Block, G.A.4
Giachelli, C.5
Hruska, K.A.6
-
4
-
-
0034767985
-
Control of serum phosphorus: Implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis)
-
G.A. Block Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis) Curr Opin Nephrol Hypertens 10 2001 741 747
-
(2001)
Curr Opin Nephrol Hypertens
, vol.10
, pp. 741-747
-
-
Block, G.A.1
-
5
-
-
5444226538
-
Mechanisms of vascular calcification in uremia
-
C.M. Giachelli Mechanisms of vascular calcification in uremia Semin Nephrol 24 2004 401 402
-
(2004)
Semin Nephrol
, vol.24
, pp. 401-402
-
-
Giachelli, C.M.1
-
7
-
-
0030947025
-
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
-
G. Luo, P. Ducy, M.D. McKee, G.J. Pinero, E. Loyer, and R.R. Behringer Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein Nature 386 1997 78 81
-
(1997)
Nature
, vol.386
, pp. 78-81
-
-
Luo, G.1
Ducy, P.2
McKee, M.D.3
Pinero, G.J.4
Loyer, E.5
Behringer, R.R.6
-
8
-
-
0141919775
-
Mineral exploration: Search for the mechanism of vascular calcification and beyond: The 2003 Jeffrey M. Hoeg award lecture
-
L.L. Demer, and Y. Tintut Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg award lecture Arterioscler Thromb Vasc Biol 23 2003 1739 1743
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1739-1743
-
-
Demer, L.L.1
Tintut, Y.2
-
9
-
-
0035571591
-
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques
-
C.R. Dhore, J.P. Cleutjens, E. Lutgens, K.B. Cleutjens, P.P. Geusens, and P.J. Kitslaar Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques Arterioscler Thromb Vasc Biol 21 2001 1998 2003
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 1998-2003
-
-
Dhore, C.R.1
Cleutjens, J.P.2
Lutgens, E.3
Cleutjens, K.B.4
Geusens, P.P.5
Kitslaar, P.J.6
-
10
-
-
0032079445
-
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
-
N. Bucay, I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, and C. Capparelli Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1998 1260 1268
-
(1998)
Genes Dev
, vol.12
, pp. 1260-1268
-
-
Bucay, N.1
Sarosi, I.2
Dunstan, C.R.3
Morony, S.4
Tarpley, J.5
Capparelli, C.6
-
11
-
-
0037152187
-
Inactivation of the osteopontin gene enhances vascular calcification of matrix gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo
-
M.Y. Speer, M.D. McKee, R.E. Guldberg, L. Liaw, H.Y. Yang, and E. Tung Inactivation of the osteopontin gene enhances vascular calcification of matrix gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo J Exp Med 196 2002 1047 1055
-
(2002)
J Exp Med
, vol.196
, pp. 1047-1055
-
-
Speer, M.Y.1
McKee, M.D.2
Guldberg, R.E.3
Liaw, L.4
Yang, H.Y.5
Tung, E.6
-
12
-
-
0035824898
-
Smooth muscle cell phenotypic transition associated with calcification-upregulation of Cbfa1 and downregulation of smooth muscle lineage markers
-
S.A. Steitz, M.Y. Speer, G. Curinga, H.Y. Yang, P. Haynes, and R. Aebersold Smooth muscle cell phenotypic transition associated with calcification-upregulation of Cbfa1 and downregulation of smooth muscle lineage markers Circ Res 89 2001 1147 1154
-
(2001)
Circ Res
, vol.89
, pp. 1147-1154
-
-
Steitz, S.A.1
Speer, M.Y.2
Curinga, G.3
Yang, H.Y.4
Haynes, P.5
Aebersold, R.6
-
13
-
-
0344393597
-
Multilineage potential of cells from the artery wall
-
Y. Tintut, Z. Alfonso, T. Saini, K. Radcliff, K. Watson, and K. Bostrom Multilineage potential of cells from the artery wall Circulation 108 2003 2505 2510
-
(2003)
Circulation
, vol.108
, pp. 2505-2510
-
-
Tintut, Y.1
Alfonso, Z.2
Saini, T.3
Radcliff, K.4
Watson, K.5
Bostrom, K.6
-
14
-
-
0034730291
-
Phosphate regulation of vascular smooth muscle cell calcification
-
S. Jono, M.D. McKee, C.E. Murry, A. Shioi, Y. Nishizawa, and K. Mori Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 2000 e10 e17
-
(2000)
Circ Res
, vol.87
-
-
Jono, S.1
McKee, M.D.2
Murry, C.E.3
Shioi, A.4
Nishizawa, Y.5
Mori, K.6
-
15
-
-
0036406957
-
Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells
-
N.X. Chen, K.D. O'Neill, D. Duan, and S.M. Moe Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells Kidney Int 62 2002 1724 1731
-
(2002)
Kidney Int
, vol.62
, pp. 1724-1731
-
-
Chen, N.X.1
O'Neill, K.D.2
Duan, D.3
Moe, S.M.4
-
16
-
-
0027367239
-
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques
-
C.M. Giachelli, N. Bae, M. Almeida, D.T. Denhardt, C.E. Alpers, and S.M. Schwartz Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques J Clin Invest 92 1993 1686 1696
-
(1993)
J Clin Invest
, vol.92
, pp. 1686-1696
-
-
Giachelli, C.M.1
Bae, N.2
Almeida, M.3
Denhardt, D.T.4
Alpers, C.E.5
Schwartz, S.M.6
-
17
-
-
0028136961
-
Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis
-
L.A. Fitzpatrick, A. Severson, W.D. Edwards, and R.T. Ingram Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis J Clin Invest 94 1994 1597 1604
-
(1994)
J Clin Invest
, vol.94
, pp. 1597-1604
-
-
Fitzpatrick, L.A.1
Severson, A.2
Edwards, W.D.3
Ingram, R.T.4
-
18
-
-
0034061786
-
Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis
-
M. Takemoto, K. Yokote, M. Nishimura, T. Shigematsu, T. Hasegawa, and S. Kon Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis Arterioscler Thromb Vasc Biol 20 2000 624 628
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 624-628
-
-
Takemoto, M.1
Yokote, K.2
Nishimura, M.3
Shigematsu, T.4
Hasegawa, T.5
Kon, S.6
-
19
-
-
0034995079
-
Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells
-
S. Ahmed, K.D. O'Neill, A.F. Hood, A.P. Evan, and S.M. Moe Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells Am J Kidney Dis 37 2001 1267 1276
-
(2001)
Am J Kidney Dis
, vol.37
, pp. 1267-1276
-
-
Ahmed, S.1
O'Neill, K.D.2
Hood, A.F.3
Evan, A.P.4
Moe, S.M.5
-
20
-
-
0028823030
-
Osteopontin is expressed in human aortic valvular lesions
-
K.D. O'Brien, J. Kuusisto, D.D. Reichenbach, M. Ferguson, C. Giachelli, and C.E. Alpers Osteopontin is expressed in human aortic valvular lesions Circulation 92 1995 2163 2168
-
(1995)
Circulation
, vol.92
, pp. 2163-2168
-
-
O'Brien, K.D.1
Kuusisto, J.2
Reichenbach, D.D.3
Ferguson, M.4
Giachelli, C.5
Alpers, C.E.6
-
21
-
-
0030937408
-
Osteopontin is associated with bioprosthetic heart valve calcification in humans
-
M. Shen, P. Marie, D. Farge, S. Carpentier, C. De Pollak, and M. Hott Osteopontin is associated with bioprosthetic heart valve calcification in humans C R Acad Sci Ser III 320 1997 49 57
-
(1997)
C R Acad Sci Ser III
, vol.320
, pp. 49-57
-
-
Shen, M.1
Marie, P.2
Farge, D.3
Carpentier, S.4
De Pollak, C.5
Hott, M.6
-
22
-
-
1642284407
-
Regulation of cardiovascular calcification
-
M.Y. Speer, and C.M. Giachelli Regulation of cardiovascular calcification Cardiovasc Pathol 13 2004 63 70
-
(2004)
Cardiovasc Pathol
, vol.13
, pp. 63-70
-
-
Speer, M.Y.1
Giachelli, C.M.2
-
23
-
-
0000022154
-
Altered wound healing in mice lacking a functional osteopontin gene (spp1)
-
L. Liaw, D.E. Birk, C.B. Ballas, J.S. Whitsitt, J.M. Davidson, and B.L.M. Hogan Altered wound healing in mice lacking a functional osteopontin gene (spp1) J Clin Invest 101 1998 1468 1478
-
(1998)
J Clin Invest
, vol.101
, pp. 1468-1478
-
-
Liaw, L.1
Birk, D.E.2
Ballas, C.B.3
Whitsitt, J.S.4
Davidson, J.M.5
Hogan, B.L.M.6
-
24
-
-
0036900001
-
Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification
-
S.A. Steitz, M.Y. Speer, M.D. McKee, L. Liaw, M. Almeida, and H. Yang Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification Am J Pathol 161 2002 2035 2046
-
(2002)
Am J Pathol
, vol.161
, pp. 2035-2046
-
-
Steitz, S.A.1
Speer, M.Y.2
McKee, M.D.3
Liaw, L.4
Almeida, M.5
Yang, H.6
-
25
-
-
0033593622
-
Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture
-
Y.F. Wang, and P.T. Kovanen Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture Circ Res 84 1999 74 83
-
(1999)
Circ Res
, vol.84
, pp. 74-83
-
-
Wang, Y.F.1
Kovanen, P.T.2
-
26
-
-
3042559672
-
Taurine prevents beta-glycerophosphate-induced calcification in cultured rat vascular smooth muscle cells
-
J. Li, B. Zhang, Z. Huang, S. Wang, C. Tang, and J. Du Taurine prevents beta-glycerophosphate-induced calcification in cultured rat vascular smooth muscle cells Heart Vessels 19 2004 125 131
-
(2004)
Heart Vessels
, vol.19
, pp. 125-131
-
-
Li, J.1
Zhang, B.2
Huang, Z.3
Wang, S.4
Tang, C.5
Du, J.6
-
27
-
-
0032852936
-
Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells
-
K. Mori, A. Shioi, S. Jono, Y. Nishizawa, and H. Morii Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells Arterioscler Thromb Vasc Biol 19 1999 2112 2118
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 2112-2118
-
-
Mori, K.1
Shioi, A.2
Jono, S.3
Nishizawa, Y.4
Morii, H.5
-
28
-
-
0027249892
-
Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel
-
A.L. Boskey, M. Maresca, W. Ullrich, S.B. Doty, W.T. Butler, and C.W. Prince Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel Bone Miner 22 1993 147 159
-
(1993)
Bone Miner
, vol.22
, pp. 147-159
-
-
Boskey, A.L.1
Maresca, M.2
Ullrich, W.3
Doty, S.B.4
Butler, W.T.5
Prince, C.W.6
-
29
-
-
0028301910
-
Modulation of crystal formation by bone phosphoproteins: Structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation
-
G.K. Hunter, C.L. Kyle, and H.A. Goldberg Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation Biochem J 300 1994 723 728
-
(1994)
Biochem J
, vol.300
, pp. 723-728
-
-
Hunter, G.K.1
Kyle, C.L.2
Goldberg, H.A.3
-
30
-
-
0028875692
-
Post translational modifications of bovine osteopontin: Identification of twenty-eight phosphorylation and three O-glycosylation sites
-
E.S. Sorensen, P. Hojrup, and T.E. Petersen Post translational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites Protein Sci 4 1995 2040 2049
-
(1995)
Protein Sci
, vol.4
, pp. 2040-2049
-
-
Sorensen, E.S.1
Hojrup, P.2
Petersen, T.E.3
-
31
-
-
0034801338
-
Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin
-
L.W. Fisher, D.A. Torchia, B. Fohr, M.F. Young, and N.S. Fedarko Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin Biochem Biophys Res Commun 280 2001 460 465
-
(2001)
Biochem Biophys Res Commun
, vol.280
, pp. 460-465
-
-
Fisher, L.W.1
Torchia, D.A.2
Fohr, B.3
Young, M.F.4
Fedarko, N.S.5
-
32
-
-
0036688817
-
Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone
-
A.L. Boskey, L. Spevak, E. Paschalis, S.B. Doty, and M.D. McKee Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone Calcif Tissue Int 71 2002 145 154
-
(2002)
Calcif Tissue Int
, vol.71
, pp. 145-154
-
-
Boskey, A.L.1
Spevak, L.2
Paschalis, E.3
Doty, S.B.4
McKee, M.D.5
-
33
-
-
0042855996
-
The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility
-
M.A. Chellaiah, and K.A. Hruska The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility Calcif Tissue Int 72 2003 197 205
-
(2003)
Calcif Tissue Int
, vol.72
, pp. 197-205
-
-
Chellaiah, M.A.1
Hruska, K.A.2
-
34
-
-
12244312775
-
Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression
-
M.A. Chellaiah, N. Kizer, R. Biswas, U. Alvarez, J. Strauss-Schoenberger, and L. Rifas Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression Mol Biol Cell 14 2003 173 189
-
(2003)
Mol Biol Cell
, vol.14
, pp. 173-189
-
-
Chellaiah, M.A.1
Kizer, N.2
Biswas, R.3
Alvarez, U.4
Strauss-Schoenberger, J.5
Rifas, L.6
|